Newsletter

Digital Health Insights

Expert analysis on longevity, GLP-1 therapies, synbiotics, digital health, and wellness innovation.

Latest issue 2026-10-17 · 7 pieces

Equity

Equitable Diagnostics and Medicine Access for All Clinics

Equitable distribution of diagnostics and medicines requires deliberate redesign of supply chains so that every clinic can obtain reliable tools and treatments regardless of location or patient income.

2026-10-17 · Read the essay

  1. 02

    Population health

    India's Population Health Push Targets Preventive Reach

    Population health approaches across India are moving from hospital-centric treatment toward community-level prevention and coordination that spans urban and rural settings.

  2. 03

    Homecare

    Nurses Lead Hospital-at-Home Programs Through Daily Remote Checks

    Hospital-at-home programs now let nurses direct continuous monitoring and care decisions for patients who would otherwise occupy inpatient beds.

  3. 04

    Health economics

    Prevention Spending: Who Pays and Where Savings Accrue

    Prevention programs shift financial burdens across payers, providers, and patients, yet realized savings frequently land outside the original investor.

  4. 05

    Synbiotics

    Synbiotics Move from Shelves to Structured Care Pathways

    Synbiotics are shifting from consumer supplements into defined clinical pathways that link gut modulation directly to diagnosis, monitoring, and follow-up.

  5. 06

    Longevity

    Tracking Biological Age: Clinic Limits Operators Must Know

    Operators evaluating longevity clinics need clear methods to assess biological age claims against measurable clinical outputs.

  6. 07

    Equity

    Equitable Access: Distributing Diagnostics and Medicines Fairly

    Equitable distribution of diagnostics and medicines requires deliberate redesign of supply chains, financing, and clinical workflows to reach every patient population without bias.

  7. 08

    GLP-1

    GLP-1 Therapies Expand Past Weight Loss Into Access and Gut Realities

    GLP-1 therapies now require attention to access barriers, patient follow-through, and gastrointestinal effects that shape daily practice beyond initial weight reduction.

Digital Health Insights | Dr. Vasanthan Metupalle | Dr. Vas Metupalle